UnitedHealth Group Incorporated
NYSE:UNHMedical - Healthcare Plans
+$3.69 today
- Market cap
- $313.53B
- Beta
- 0.65
- P/E (TTM)
- 30.5
- EPS (TTM)
- $13.24
- Dividend yield
- 2.22%
Volume 17.34M
Average 8.23M
UNH Operating Cash Flow
Cash generated by the company's core business operations during the period.
UnitedHealth Group IncorporatedNYSE: UNH
Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Operating cash flow dips below year-ago levels
Q3 FY2026 operating cash flow of $5.12B fell 13.8% year over year, behind the +25.0% change in trailing-twelve-month operating cash flow. Sequentially, it fell 53.6% from the prior quarter. Over 3 fiscal years it compounded at -9.1% a year.
Context
- Operating cash flow amounted to 4.4% of revenue in FY2025, down 1.6 pp from a year earlier.
- Operating cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -13.8% toward the trailing-twelve-month pace of +25.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 19.7B USD
- Year-over-year change
- -18.6%
- 4-year CAGR
- -3.1%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.7B | -18.6% |
| FY2024 | 2024-12-31 | 24.2B | -16.7% |
| FY2023 | 2023-12-31 | 29.07B | +10.9% |
| FY2022 | 2022-12-31 | 26.21B | +17.3% |
| FY2021 | 2021-12-31 | 22.34B | — |
Operating Cash Flow vs competitors
How UNH compares with its peers on the latest reported figures
- UNH's LTM Sep 2026 operating cash flow of $26.2B is the largest of the 9 companies compared; the peer median is $5.98B.
- Its year-over-year change of +25.0% is the 7th highest of 9, against a peer median of +133.5%.
- Operating cash flow amounts to 5.8% of revenue for UNH, versus a peer median of 3.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $26.2B | +25.0% | -9.1% | 5.8% | |
| LTM Jun 2026 | $14.78B | +95.3% | -13.0% | 3.6% | |
| LTM Jun 2026 | $9.77B | +464.5% | -6.7% | 5.0% | |
| LTM Sep 2026 | $9.43B | +8.8% | +3.5% | 3.3% | |
| LTM Sep 2026 | $7.6B | +54.6% | -20.1% | 3.8% | |
| LTM Jun 2026 | $4.37B | +254.3% | +42.3% | 28.6% | |
| LTM Sep 2026 | $1.34B | -34.5% | -41.4% | 0.9% | |
| LTM Sep 2026 | $331M | +171.8% | — | 0.8% | |
| LTM Mar 2026 | $251.99M | +337.3% | — | 5.9% | |
| Peer median (excluding UNH) | $5.98B | +133.5% | -9.9% | 3.7% | |
Competitors are the stored peer set for UNH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 17.29B | 20.12B | 22.38B | 15.24B | 12.81B |
| Depreciation & Amortization | 3.1B | 3.4B | 3.97B | 4.1B | 4.36B |
| Deferred Income Tax | (814M) | (673M) | (245M) | (296M) | (989M) |
| Stock-Based Compensation | 800M | 925M | 1.06B | 1.02B | 971M |
| Change in Working Capital | 1.52B | 2.25B | 1.64B | (808M) | 2.28B |
| Accounts Receivables | (1B) | (2.52B) | (3.11B) | (1.44B) | 0 |
| Inventory | (1.03B) | 0 | 1.04B | 0 | 0 |
| Accounts Payables | 3.86B | 1.96B | 3.52B | 2.46B | 0 |
| Other Working Capital | (310M) | 2.81B | 203M | (1.83B) | 2.28B |
| Other Non-Cash Items | 447M | 188M | 258M | 4.95B | 265M |
| Operating Cash Flow | 22.34B | 26.21B | 29.07B | 24.2B | 19.7B |
| Capital Expenditures | (2.45B) | (2.8B) | (3.39B) | (3.5B) | (3.62B) |
| Acquisitions (Net) | (4.82B) | (21.46B) | (10.14B) | (13.41B) | (4.51B) |
| Purchases of Investments | (1.84B) | (18.83B) | (18.31B) | (27.31B) | 0 |
| Sales of Investments | 15.3B | 11.99B | 16.54B | 27.83B | 361M |
| Other Investing Activities | (16.55B) | 2.62B | (275M) | (4.15B) | (915M) |
| Investing Cash Flow | (10.37B) | (28.48B) | (15.57B) | (20.53B) | (8.69B) |
| Debt Repayment | 2.48B | 12.54B | 4.28B | 14.66B | 726M |
| Common Stock Issued | 1.36B | 1.25B | 1.35B | 1.85B | 0 |
| Common Stock Repurchased | (5B) | (7B) | (8B) | (9B) | (5.55B) |
| Dividends Paid | (5.28B) | (5.99B) | (6.76B) | (7.53B) | (7.92B) |
| Other Financing Activities | 344M | 3.43B | (2.4B) | (3.49B) | 1.09B |
| Financing Cash Flow | (7.46B) | 4.23B | (11.53B) | (3.51B) | (11.64B) |
| Effect of Forex Changes | (62M) | 34M | 97M | (280M) | 3.44B |
| Net Change in Cash | 4.45B | 1.99B | 2.06B | (115M) | 2.81B |
| Free Cash Flow | 19.89B | 23.4B | 25.68B | 20.71B | 16.08B |
UnitedHealth Group Incorporated
NYSE:UNH
Intrinsic Alpha fair value
Locked
Current Price
$349.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.